Camu Camu Seeds (Myrciaria dubia)

Camu camu seeds (Myrciaria dubia) are rich in ellagitannins, ellagic acid, and proanthocyanidins that drive potent antioxidant activity via free radical scavenging and metal ion chelation. The seed fraction exhibits antiproliferative effects against human cancer cell lines through mechanisms distinct from the fruit pulp's well-studied vitamin C content.

Origin & History

Camu camu seeds derive from Myrciaria dubia, a small tree native to the Amazon rainforest of Peru, Brazil, and surrounding regions where the fruit grows wild along riverbanks. The seeds are obtained by separating them from ripe fruit, then processed through extraction methods like lyophilization or solvent partitioning to isolate phenolic-rich compounds including ellagitannins and acylphloroglucinols.

Historical & Cultural Context

No traditional medicinal use specifically for camu camu seeds has been documented; indigenous Amazonian peoples have historically consumed the fruit for its high vitamin C content since pre-colonial times. Seeds were typically discarded, with modern research focusing on their waste valorization rather than traditional applications.

Health Benefits

• Antioxidant activity demonstrated through DPPH radical scavenging and metal chelation in laboratory studies (preliminary evidence only)
• Antiproliferative effects on cancer cell lines (HepG2 and Caco-2) with IC50 values of 1,116 µg/mL and 608.5 µg/mL respectively in vitro (no human studies)
• Enzyme inhibition of α-amylase, α-glucosidase, and ACE shown in laboratory tests (preliminary evidence, no clinical trials)
• Antimicrobial activity from acylphloroglucinol compounds demonstrated in vitro (no human data)
• High phenolic content (46.3% in lyophilized extracts) including ellagitannins and procyanidins (in vitro evidence only)

How It Works

Ellagitannins and ellagic acid in camu camu seeds scavenge DPPH free radicals and chelate pro-oxidant metal ions such as iron and copper, reducing oxidative stress at the cellular level. Ellagic acid also inhibits topoisomerase II and modulates apoptotic pathways, which may explain the antiproliferative IC50 values of 608.5 µg/mL against Caco-2 colon cancer cells and 1,116 µg/mL against HepG2 hepatocellular carcinoma cells observed in vitro. Proanthocyanidins present in the seed matrix further contribute by inhibiting lipid peroxidation and suppressing NF-κB-mediated inflammatory signaling.

Scientific Research

Research on camu camu seeds is limited entirely to in vitro laboratory studies with no human clinical trials, RCTs, or meta-analyses identified. The primary study (PMID: 31759605) tested lyophilized seed extract on cancer cell lines, demonstrating antiproliferative and antioxidant effects, but human efficacy remains unestablished.

Clinical Summary

Evidence for camu camu seed bioactivity is currently limited to in vitro laboratory studies; no published human clinical trials have evaluated seed extracts specifically. DPPH radical scavenging assays and metal chelation models confirm antioxidant capacity, and antiproliferative effects were quantified against HepG2 and Caco-2 cell lines with IC50 values of 1,116 µg/mL and 608.5 µg/mL respectively. These concentrations are pharmacologically high and may not be achievable through oral supplementation, making translation to human benefit uncertain. The broader camu camu fruit has more extensive human research focused on vitamin C content, but seed-specific clinical data remains absent.

Nutritional Profile

Camu camu seeds (Myrciaria dubia) are the by-product fraction separated from the pulp and represent a distinct nutritional matrix from the fruit pulp. Macronutrient composition per 100g dry weight (approximate, based on limited seed-specific studies): crude protein 6–9g, crude fat 3–7g (seed oil fraction contains fatty acids including lauric, palmitic, and oleic acids), total carbohydrates 60–70g, crude fiber 20–35g (high insoluble dietary fiber content, primarily cellulose and lignin fractions). Moisture content in fresh seeds approximately 50–60%, dropping significantly upon drying. Bioactive compounds are the most characterized fraction: condensed tannins (proanthocyanidins) are the dominant polyphenol class in seeds, reported at 15–40mg catechin equivalents/g dry weight depending on extraction method; ellagitannins including ellagic acid derivatives have been identified; flavonoids including quercetin and rutin glycosides present at lower concentrations than pulp. Total polyphenol content in seed extracts reported at approximately 80–200mg GAE/g dry weight (substantially higher than pulp due to concentration of tannins). Vitamin C (ascorbic acid), the hallmark compound of camu camu pulp, is present in seeds at markedly lower concentrations than pulp (<50mg/100g fresh weight estimated); seeds are not a meaningful vitamin C source. Mineral content includes calcium, magnesium, potassium, and trace manganese, with specific seed concentrations poorly characterized in peer-reviewed literature. Bioavailability note: high tannin content in seeds may inhibit protein digestibility and reduce mineral bioavailability (iron, zinc) through chelation; the antinutritional effects of condensed tannins are a relevant consideration for direct human consumption. Seed oil, if cold-pressed, represents a minor but distinct lipid fraction with potential functional applications. Overall, seeds are primarily a source of dietary fiber and polyphenolic antioxidants rather than vitamins or protein.

Preparation & Dosage

No clinically studied dosages exist as human trials on camu camu seeds are absent. In vitro studies used concentrations of 608.5-1,116 µg/mL for antiproliferative effects, but these cannot be translated to human doses. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, quercetin, resveratrol, green tea extract, pomegranate extract

Safety & Interactions

No human safety trials have been conducted specifically on camu camu seed extracts, making a formal adverse effect profile unavailable at this time. The high tannin content typical of ellagitannin-rich seeds may reduce absorption of dietary minerals such as iron and zinc and could cause gastrointestinal discomfort including nausea or constipation at elevated doses. Ellagic acid has demonstrated CYP3A4 enzyme inhibitory activity in vitro, suggesting potential interactions with drugs metabolized by this pathway, including certain statins, immunosuppressants, and anticoagulants. Pregnant and breastfeeding individuals should avoid supplemental seed extracts due to the complete absence of safety data in these populations.